glp-1 receptor agonists should be avoided in patients with – Peripheral Brain The GLP-1 Agonists and Obesity:
Description
doi: 10.1517/14656566.8.15.2593 47 BrayGM
Brussels: IDF
36 BMI was found to be significantly reduced in the GLP-1 RA group
Additionally, the growing incidence of diabetes is also increasing its demand
